United Pharm (033270) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.077x

Based on the latest financial reports, United Pharm (033270) has a cash flow conversion efficiency ratio of 0.077x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩35.58 Billion ≈ $24.12 Million USD) by net assets (₩459.17 Billion ≈ $311.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See United Pharm balance sheet independence to measure how much of total assets are equity-financed.

United Pharm - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how United Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 033270 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

United Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of United Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Niu Technologies F:0O9	N/A
Melar Acquisition Corp. I Class A Ordinary Shares NASDAQ:MACI	-0.001x
Galata Acquisition Corp. II Class A Ordinary Shares NASDAQ:LATA	-0.001x
Answer Technology Co Ltd TW:3528	-1.025x
Tele2 AB (publ) ST:TEL2-A	0.118x
Inogen Inc NASDAQ:INGN	-0.037x
Gencor Industries Inc NYSE MKT:GENC	0.052x
Bluerock Acquisition Corp. Class A Ordinary Shares NASDAQ:BLRK	10.328x

Annual Cash Flow Conversion Efficiency for United Pharm (2011–2025)

The table below shows the annual cash flow conversion efficiency of United Pharm from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 033270 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩454.63 Billion ≈ $308.10 Million	₩51.14 Billion ≈ $34.65 Million	0.112x	+70.52%
2024-12-31	₩406.21 Billion ≈ $275.28 Million	₩26.79 Billion ≈ $18.16 Million	0.066x	-49.81%
2023-12-31	₩378.68 Billion ≈ $256.63 Million	₩49.77 Billion ≈ $33.73 Million	0.131x	-30.38%
2022-12-31	₩337.86 Billion ≈ $228.96 Million	₩63.78 Billion ≈ $43.22 Million	0.189x	+28.77%
2021-12-31	₩300.71 Billion ≈ $203.79 Million	₩44.09 Billion ≈ $29.88 Million	0.147x	+9.82%
2020-12-31	₩276.89 Billion ≈ $187.65 Million	₩36.96 Billion ≈ $25.05 Million	0.133x	-10.75%
2019-12-31	₩255.10 Billion ≈ $172.88 Million	₩38.15 Billion ≈ $25.86 Million	0.150x	-7.30%
2018-12-31	₩228.48 Billion ≈ $154.84 Million	₩36.86 Billion ≈ $24.98 Million	0.161x	+17.54%
2017-12-31	₩201.68 Billion ≈ $136.68 Million	₩27.68 Billion ≈ $18.76 Million	0.137x	-18.90%
2016-12-31	₩177.39 Billion ≈ $120.21 Million	₩30.02 Billion ≈ $20.34 Million	0.169x	+28.50%
2014-12-31	₩161.83 Billion ≈ $109.67 Million	₩21.31 Billion ≈ $14.44 Million	0.132x	-1.80%
2013-12-31	₩141.44 Billion ≈ $95.85 Million	₩18.97 Billion ≈ $12.85 Million	0.134x	-18.19%
2012-12-31	₩133.48 Billion ≈ $90.46 Million	₩21.88 Billion ≈ $14.83 Million	0.164x	-32.90%
2011-12-31	₩113.04 Billion ≈ $76.61 Million	₩27.62 Billion ≈ $18.72 Million	0.244x	--

About United Pharm

KO:033270 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$174.70 Million

₩257.78 Billion KRW

Market Cap Rank

#17011 Global

#637 in Korea

Share Price

₩17850.00

Change (1 day)

+2.00%

52-Week Range

₩16600.00 - ₩21400.00

All Time High

₩95918.11